Shares of Viatris Inc. advanced 5.44% to $13.37 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.19% to 6,963.74 and Dow Jones ...

In the past six months alone, the company’s stock price has increased by a massive 41.5%, reaching $13.07 per share. This was ...

Viatris Inc. closed 6.15% short of its 52-week high of $13.49, which the company reached on January 14th.

Viatris Inc. (VTRS) delivered second-quarter 2025 adjusted earnings of 62 cents per share, which beat the Zacks Consensus Estimate of 56 cents. The company recorded adjusted earnings of 69 cents per ...

Viatris (VTRS) is set to report Q3 results on Thursday, November 6, before the market opens. Analysts expect EPS of $0.62, down 17.3% year-over-year, and revenue of $3.6B, a 5.3% decline. Viatris ...

If you are wondering whether Viatris might still offer value at its current share price, this article walks through what the ...

Viatris is set to report its fourth-quarter earnings soon, with analysts forecasting a slight decline in profits.

Viatris Inc. (NASDAQ:VTRS) on Thursday, released data from Phase 3 study evaluating the contraceptive efficacy and safety of XULANE LO low dose weekly dermal patch of 150 mcg norelgestromin and 17.5 ...

Viatris Inc. closed 3.26% short of its 52-week high of $13.49, which the company reached on January 14th. Supported by ...